Infectious Disease Diagnostics – News and Features

Synthetic biology techniques have emerged as transformative tools in the tug-of-war between humans and drug-resistant bacteria. Discover how researchers are utilizing synthetic biology techniques to engineer new antimicrobials.

A tiny, four-fingered “hand” folded from a single piece of DNA can pick up the virus that causes COVID-19 for highly sensitive rapid detection and can even block viral particles from entering cells to infect them.

A new AI tool could identify more people suffering from long COVID from their health records, potentially transforming the diagnostic process.

A study from Emory University reveals that autoantibodies found in the nasal cavity can help predict and improve COVID-19 recovery. The research indicates that these antibodies regulate inflammation and enhance antiviral immunity.

A study by King's College London and Guy's and St Thomas’ NHS Foundation Trust reveals how AI can quickly assess antimicrobial resistance in ICU patients. This machine learning approach provides same-day diagnostics.

Researchers have developed an AI model, “EUCAST-GPT-expert,” using GPT-4 to analyze antibiotic resistance through the Kirby-Bauer disk diffusion test. While the AI tool aids in identifying resistance, it is not as accurate as human experts.

A new study shows that mild SARS-CoV-2 infections during pregnancy can trigger immune responses that cause inflammation in a developing fetus.

Researchers developed innovative origami-paper sensors for detecting infectious disease biomarkers in wastewater. This low-cost, user-friendly method allows for rapid results via mobile phone cameras.

A GRAM Project study forecasts a sharp rise in deaths from antimicrobial resistance, predicting over 39 million lives lost by 2050 without action. Annual deaths could rise significantly, highlighting the urgent need for improved interventions.

Researchers have found a way to produce and test huge collections of molecules, known as DNA-encoded chemical libraries (DEL), using magnetic particles. The technology of DEL promises to find new active pharmaceutical ingredients.